Discover the full record of transactions filed by FINKELSTEIN J J, Chief Executive Officer. Officer active across 1 companies, notably Regenerx Biopharmaceuticals INC. Cumulatively, 2 reports have been logged. Total volume traded: €25k. The latest transaction was disclosed on 30 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
FINKELSTEIN J J serves as President and CEO at Regenerx Biopharmaceuticals Inc. He is responsible for the strategic and operational direction of the company. J J plays a key role in business development and technological innovation, contributing to the growth of Regenerx. His expertise in the biopharmaceutical sector is essential for navigating a competitive environment.